INSUBUY, LLC – Trademark Portfolio

Entity Type: 16

INSUBUY, LLC holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 15 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 13 trademarks are registered. Notable registered marks include INSUBUY, OMNISECURE, PROTECTFLEX, BROKERSNEXUS, and EXCHANGEGUARD. The owner is based in PLANO, TX.

4200 MAPLESHADE LANE, SUITE 200

PLANO, TX 75093

15 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

INSUBUY, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (15 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does INSUBUY, LLC have?

INSUBUY, LLC has 15 U.S. trademarks filed with the USPTO. Of these, 13 registered, 1 abandoned, 1 cancelled.

What trademark classes does INSUBUY, LLC file in?

INSUBUY, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 42 (Computer & Scientific). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are INSUBUY, LLC's most well-known trademarks?

INSUBUY, LLC's registered trademark portfolio includes well-known marks such as INSUBUY, OMNISECURE, PROTECTFLEX, BROKERSNEXUS, and EXCHANGEGUARD. These are among 13 currently registered trademarks in the portfolio.

What is INSUBUY, LLC's trademark registration success rate?

INSUBUY, LLC has a 87% trademark registration rate, with 13 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.